IN186768B - - Google Patents

Info

Publication number
IN186768B
IN186768B IN2893DE1996A IN186768B IN 186768 B IN186768 B IN 186768B IN 2893DE1996 A IN2893DE1996 A IN 2893DE1996A IN 186768 B IN186768 B IN 186768B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Herve Bouchard
Alain Commercon
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Priority to IN419DE2000 priority Critical patent/IN188680B/en
Publication of IN186768B publication Critical patent/IN186768B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IN2893DE1996 1995-12-22 1996-12-20 IN186768B (enExample)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN419DE2000 IN188680B (enExample) 1995-12-22 2000-04-10

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9515379A FR2742751B1 (fr) 1995-12-22 1995-12-22 Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
IN186768B true IN186768B (enExample) 2001-11-03

Family

ID=9485871

Family Applications (4)

Application Number Title Priority Date Filing Date
IN2893DE1996 IN186768B (enExample) 1995-12-22 1996-12-20
IN419DE2000 IN188680B (enExample) 1995-12-22 2000-04-10
IN421DE2000 IN188470B (enExample) 1995-12-22 2000-04-10
IN420DE2000 IN188469B (enExample) 1995-12-22 2000-04-10

Family Applications After (3)

Application Number Title Priority Date Filing Date
IN419DE2000 IN188680B (enExample) 1995-12-22 2000-04-10
IN421DE2000 IN188470B (enExample) 1995-12-22 2000-04-10
IN420DE2000 IN188469B (enExample) 1995-12-22 2000-04-10

Country Status (40)

Country Link
US (1) US5728849A (enExample)
EP (1) EP0876362B1 (enExample)
JP (1) JP3953106B2 (enExample)
KR (1) KR100500351B1 (enExample)
CN (1) CN1103766C (enExample)
AR (1) AR005197A1 (enExample)
AT (1) ATE250593T1 (enExample)
AU (1) AU712597B2 (enExample)
BG (1) BG63204B1 (enExample)
BR (1) BR9612135A (enExample)
CA (1) CA2238884C (enExample)
CO (1) CO4520184A1 (enExample)
CZ (1) CZ294972B6 (enExample)
DE (1) DE69630145T2 (enExample)
DK (1) DK0876362T3 (enExample)
DZ (1) DZ2149A1 (enExample)
EA (1) EA001533B1 (enExample)
ES (1) ES2202490T3 (enExample)
FR (1) FR2742751B1 (enExample)
HU (1) HU225032B1 (enExample)
IL (1) IL124994A (enExample)
IN (4) IN186768B (enExample)
MA (1) MA26412A1 (enExample)
MX (1) MX9804688A (enExample)
MY (1) MY113934A (enExample)
NO (1) NO317358B1 (enExample)
NZ (1) NZ324337A (enExample)
OA (1) OA10700A (enExample)
PE (1) PE25198A1 (enExample)
PL (1) PL189311B1 (enExample)
PT (1) PT876362E (enExample)
RO (1) RO116194B1 (enExample)
SK (1) SK282835B6 (enExample)
TN (1) TNSN96169A1 (enExample)
TR (1) TR199801179T2 (enExample)
TW (1) TW371659B (enExample)
UA (1) UA48205C2 (enExample)
UY (1) UY24386A1 (enExample)
WO (1) WO1997023473A1 (enExample)
ZA (1) ZA9610737B (enExample)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9920548D0 (en) * 1999-08-31 1999-11-03 Rhone Poulenc Rorer Sa Treatment of hepatocellular carcinoma
NZ514074A (en) 2000-02-02 2004-03-26 Univ Florida State Res Found C10 carbonate substituted taxanes as antitumor agents
MXPA03007349A (es) * 2001-02-24 2003-12-04 Boehringer Ingelheim Pharma Derivados de xantina, su preparacion y su empleo como medicamentos.
US7407955B2 (en) 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
WO2004103344A1 (en) * 2003-05-20 2004-12-02 Aronex Pharmaceuticals, Inc. Combination chemotherapy comprising a liposomal platinum complex
US7501426B2 (en) 2004-02-18 2009-03-10 Boehringer Ingelheim International Gmbh 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
DE102004054054A1 (de) 2004-11-05 2006-05-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
EP1669358A1 (en) 2004-12-07 2006-06-14 Aventis Pharma S.A. Cytotoxic agents comprising new taxanes
DE102005035891A1 (de) 2005-07-30 2007-02-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
EP1852108A1 (en) 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG DPP IV inhibitor formulations
NZ600394A (en) 2006-05-04 2014-04-30 Boehringer Ingelheim Int Polymorphs of a dpp-iv enzyme inhibitor
PE20080251A1 (es) 2006-05-04 2008-04-25 Boehringer Ingelheim Int Usos de inhibidores de dpp iv
US20080207743A1 (en) * 2007-02-28 2008-08-28 Rodger Lamb Biologically Active Taxane Analogs and Methods of Treatment
ES2733348T3 (es) * 2007-08-17 2019-11-28 Boehringer Ingelheim Int Derivados de purina para uso en el tratamiento de enfermedades relacionadas con FAP
AR071175A1 (es) 2008-04-03 2010-06-02 Boehringer Ingelheim Int Composicion farmaceutica que comprende un inhibidor de la dipeptidil-peptidasa-4 (dpp4) y un farmaco acompanante
PE20100156A1 (es) * 2008-06-03 2010-02-23 Boehringer Ingelheim Int Tratamiento de nafld
KR20190016601A (ko) 2008-08-06 2019-02-18 베링거 인겔하임 인터내셔날 게엠베하 메트포르민 요법이 부적합한 환자에서의 당뇨병 치료
UY32030A (es) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
CA2735562C (en) * 2008-08-15 2017-10-17 Boehringer Ingelheim International Gmbh Dpp-4 inhibitors for wound healing
MX2011002558A (es) 2008-09-10 2011-04-26 Boehringer Ingelheim Int Terapia de combinacion para el tratamiento de diabetes y estados relacionados.
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
CA2745037C (en) 2008-12-23 2020-06-23 Boehringer Ingelheim International Gmbh Salt forms of 1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8(3-(r)-amino-piperidin-1-yl)-xanthine
AR074990A1 (es) 2009-01-07 2011-03-02 Boehringer Ingelheim Int Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina
CN102753161A (zh) 2009-11-27 2012-10-24 贝林格尔.英格海姆国际有限公司 基因型糖尿病患者利用dpp-iv抑制剂例如利拉利汀的治疗
CN107961377B (zh) 2010-05-05 2022-11-22 勃林格殷格翰国际有限公司 组合疗法
MX2012014247A (es) 2010-06-24 2013-01-18 Boehringer Ingelheim Int Terapia para la diabetes.
AR083878A1 (es) 2010-11-15 2013-03-27 Boehringer Ingelheim Int Terapia antidiabetica vasoprotectora y cardioprotectora, linagliptina, metodo de tratamiento
PL2731947T3 (pl) 2011-07-15 2019-07-31 Boehringer Ingelheim International Gmbh Podstawiona dimeryczna pochodna chinazoliny, sposób jej wytwarzania i jej zastosowanie w kompozycjach farmaceutycznych do leczenia cukrzycy typu I i II
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
US20130303462A1 (en) 2012-05-14 2013-11-14 Boehringer Ingelheim International Gmbh Use of a dpp-4 inhibitor in podocytes related disorders and/or nephrotic syndrome
US20130303554A1 (en) 2012-05-14 2013-11-14 Boehringer Ingelheim International Gmbh Use of a dpp-4 inhibitor in sirs and/or sepsis
WO2013174767A1 (en) 2012-05-24 2013-11-28 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
EP2922818B1 (en) 2012-11-24 2018-09-05 Hangzhou Dac Biotech Co., Ltd Hydrophilic linkers and their uses for conjugation of drugs to cell binding molecules
FR3010839B1 (fr) * 2013-09-17 2017-04-21 Schneider Electric Ind Sas Dispositif de raccordement electrique d'au moins un conducteur dans une borne appartenant a un appareil electrique
WO2015128453A1 (en) 2014-02-28 2015-09-03 Boehringer Ingelheim International Gmbh Medical use of a dpp-4 inhibitor
WO2015127685A1 (en) 2014-02-28 2015-09-03 Hangzhou Dac Biotech Co., Ltd Charged linkers and their uses for conjugation
CA2991973C (en) 2015-07-12 2021-12-07 Suzhou M-Conj Biotech Co., Ltd. Bridge linkers for conjugation of a cell-binding molecule
US9839687B2 (en) 2015-07-15 2017-12-12 Suzhou M-Conj Biotech Co., Ltd. Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule
CA3022202A1 (en) 2016-06-10 2017-12-14 Boehringer Ingelheim International Gmbh Combinations of linagliptin and metformin
KR102345175B1 (ko) 2016-11-14 2021-12-31 항저우 디에이씨 바이오테크 씨오, 엘티디 결합 링커, 그러한 결합 링커를 함유하는 세포 결합 분자-약물 결합체, 링커를 갖는 그러한 결합체의 제조 및 사용
AU2021362997A1 (en) 2021-11-03 2024-05-16 Hangzhou Dac Biotech Co., Ltd. Specific conjugation of an antibody

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2017724C1 (ru) * 1990-07-12 1994-08-15 Дзе Юниверсити оф Канзас Способ получения производных таксола
US5059699A (en) * 1990-08-28 1991-10-22 Virginia Tech Intellectual Properties, Inc. Water soluble derivatives of taxol
FR2678930B1 (fr) * 1991-07-10 1995-01-13 Rhone Poulenc Rorer Sa Procede de preparation de derives de la baccatine iii et de la desacetyl-10 baccatine iii.
RU2059631C1 (ru) * 1991-11-29 1996-05-10 Дзе Юниверсити оф Канзас Производные таксола и фармацевтическая композиция, обладающая противоопухолевой активностью
WO1993021173A1 (en) * 1992-04-17 1993-10-28 Abbott Laboratories Taxol derivatives
US5254580A (en) * 1993-01-19 1993-10-19 Bristol-Myers Squibb Company 7,8-cyclopropataxanes
MX9307777A (es) * 1992-12-15 1994-07-29 Upjohn Co 7-HALO-Y 7ß, 8ß-METANO-TAXOLES, USO ANTINEOPLASTICO Y COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN.

Also Published As

Publication number Publication date
SK85398A3 (en) 1998-11-04
WO1997023473A1 (fr) 1997-07-03
KR19990076680A (ko) 1999-10-15
PE25198A1 (es) 1998-05-10
PL189311B1 (pl) 2005-07-29
MY113934A (en) 2002-06-29
EA199800588A1 (ru) 1998-12-24
NO982580L (no) 1998-06-05
CN1103766C (zh) 2003-03-26
EP0876362A1 (fr) 1998-11-11
CN1205697A (zh) 1999-01-20
ZA9610737B (en) 1997-06-27
ATE250593T1 (de) 2003-10-15
DE69630145D1 (de) 2003-10-30
UA48205C2 (uk) 2002-08-15
CZ294972B6 (cs) 2005-04-13
OA10700A (fr) 2002-11-27
MX9804688A (es) 1998-10-31
CO4520184A1 (es) 1997-10-15
ES2202490T3 (es) 2004-04-01
BG63204B1 (bg) 2001-06-29
AU1180997A (en) 1997-07-17
PT876362E (pt) 2004-02-27
MA26412A1 (fr) 2004-12-20
CA2238884C (fr) 2007-02-06
IL124994A0 (en) 1999-01-26
FR2742751B1 (fr) 1998-01-30
CZ196198A3 (cs) 1998-09-16
IL124994A (en) 2000-12-06
KR100500351B1 (ko) 2005-12-21
DZ2149A1 (fr) 2002-10-23
DK0876362T3 (da) 2004-02-02
TR199801179T2 (xx) 1998-10-21
US5728849A (en) 1998-03-17
AR005197A1 (es) 1999-04-14
JP3953106B2 (ja) 2007-08-08
RO116194B1 (ro) 2000-11-30
BG102569A (en) 1999-04-30
BR9612135A (pt) 1999-07-13
NO982580D0 (no) 1998-06-05
CA2238884A1 (fr) 1997-07-03
UY24386A1 (es) 2001-08-27
IN188469B (enExample) 2002-09-28
HUP9904046A3 (en) 2001-08-28
HU225032B1 (en) 2006-05-29
NZ324337A (en) 2000-03-27
PL327405A1 (en) 1998-12-07
DE69630145T2 (de) 2004-07-15
NO317358B1 (no) 2004-10-18
HUP9904046A1 (hu) 2001-04-28
AU712597B2 (en) 1999-11-11
EA001533B1 (ru) 2001-04-23
EP0876362B1 (fr) 2003-09-24
JP2000502671A (ja) 2000-03-07
FR2742751A1 (fr) 1997-06-27
IN188470B (enExample) 2002-09-28
HK1017895A1 (en) 1999-12-03
IN188680B (enExample) 2002-10-26
SK282835B6 (sk) 2002-12-03
TNSN96169A1 (fr) 2005-03-15
TW371659B (en) 1999-10-11

Similar Documents

Publication Publication Date Title
BR122012014331A2 (enExample)
IN187897B (enExample)
IN182130B (enExample)
IN186768B (enExample)
FR2729528B1 (enExample)
IN182137B (enExample)
IN187841B (enExample)
FR2731335B3 (enExample)
IN185632B (enExample)
IN181407B (enExample)
IN181939B (enExample)
ECSDI950273S (enExample)
IN182495B (enExample)
IN183297B (enExample)
IN187250B (enExample)
AU1627395A (enExample)
BR7501503U (enExample)
CN3035868S (enExample)
CN3034524S (enExample)
CN3035870S (enExample)
CN3035869S (enExample)
CN3036463S (enExample)
CN3035323S (enExample)
CN3035300S (enExample)
CN3034896S (enExample)